Nicole Lamanna, investigator with New York-Presbyterian/Columbia University Medical Center was highlighted recently in Cure Today by Kristie L. Kahl. Ms. Kahl notes that Dr. Lamanna…
Follow the link to Targeted Oncology for a breakdown of advances in treating chronic lymphocytic leukemia (CLL) as new agents, particularly next-generation BTK and PI3K…
AbbVie secured ownership of IMBRUVICA® (ibrutinib) in 2015 when it purchased Pharmacyclics. AbbVie reported $2.5 billion in sales with a robust 40% growth rate. It…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
